[
  {
    "text": "Confidential",
    "bbox": [
      1000,
      81,
      1000,
      93
    ],
    "label": 18,
    "category": "Anti-Assignment"
  },
  {
    "text": "Execution Version",
    "bbox": [
      1000,
      98,
      1000,
      109
    ],
    "label": 18,
    "category": "Anti-Assignment"
  },
  {
    "text": "(b)",
    "bbox": [
      195,
      115,
      218,
      128
    ],
    "label": 18,
    "category": "Anti-Assignment"
  },
  {
    "text": "the Licensee enters into a merger, consolidation or similar transaction with a Competitor (whether or not.",
    "bbox": [
      350,
      114,
      1000,
      128
    ],
    "label": 18,
    "category": "Anti-Assignment"
  },
  {
    "text": "such Party is the surviving entity) and as a result of such merger, consolidation or similar transaction (i) the managing directors or the.",
    "bbox": [
      113,
      133,
      1000,
      146
    ],
    "label": 18,
    "category": "Anti-Assignment"
  },
  {
    "text": "members of the Board of Directors of the Licensee immediately prior to such transaction constitute less than a majority of the",
    "bbox": [
      111,
      151,
      1000,
      164
    ],
    "label": 18,
    "category": "Anti-Assignment"
  },
  {
    "text": "managing directors or the members of the Board of Directors of the Licensee or such surviving person immediately following such",
    "bbox": [
      111,
      169,
      1000,
      183
    ],
    "label": 18,
    "category": "Anti-Assignment"
  },
  {
    "text": "transaction or (ii) the persons that beneficially owned, directly or indirectly, the shares of Voting Stock of the Licensee immediately",
    "bbox": [
      111,
      186,
      1000,
      200
    ],
    "label": 18,
    "category": "Anti-Assignment"
  },
  {
    "text": "prior to such transaction cease to beneficially own, directly or indirectly, shares of Voting Stock of the Licensee representing a",
    "bbox": [
      110,
      204,
      1000,
      219
    ],
    "label": 18,
    "category": "Anti-Assignment"
  },
  {
    "text": "majority of the total voting power of all outstanding classes of Voting Stock of the surviving person in substantially the same",
    "bbox": [
      112,
      223,
      1000,
      236
    ],
    "label": 18,
    "category": "Anti-Assignment"
  },
  {
    "text": "proportions as their ownership of Voting Stock of the Licensee immediately prior to such transaction.",
    "bbox": [
      111,
      240,
      944,
      255
    ],
    "label": 18,
    "category": "Anti-Assignment"
  },
  {
    "text": "1.14",
    "bbox": [
      193,
      273,
      237,
      287
    ],
    "label": 18,
    "category": "Anti-Assignment"
  },
  {
    "text": "Confidential Information means, with respect to a Party, all Know-How and all other proprietary information.",
    "bbox": [
      304,
      275,
      1000,
      288
    ],
    "label": 18,
    "category": "Anti-Assignment"
  },
  {
    "text": "of such Party, including information on the business, affairs, research and development activities, results of non-clinical and clinical.",
    "bbox": [
      113,
      293,
      1000,
      306
    ],
    "label": 18,
    "category": "Anti-Assignment"
  },
  {
    "text": "trials, national and multinational regulatory proceedings and affairs, finances, plans, contractual relationships and operations of such.",
    "bbox": [
      113,
      312,
      1000,
      324
    ],
    "label": 18,
    "category": "Anti-Assignment"
  },
  {
    "text": "Party. Furthermore, the terms and conditions of this Agreement shall be considered Confidential Information of both Parties. For the",
    "bbox": [
      113,
      329,
      1000,
      341
    ],
    "label": 18,
    "category": "Anti-Assignment"
  },
  {
    "text": "avoidance of doubt, all Know-How and proprietary information relating to the Licensed Products generated by or on behalf of Bioeq.",
    "bbox": [
      111,
      346,
      1000,
      360
    ],
    "label": 18,
    "category": "Anti-Assignment"
  },
  {
    "text": "and provided to Licensee hereunder shall be considered Confidential Information of Bioeq.",
    "bbox": [
      112,
      363,
      858,
      379
    ],
    "label": 18,
    "category": "Anti-Assignment"
  },
  {
    "text": "1.15",
    "bbox": [
      193,
      397,
      237,
      411
    ],
    "label": 18,
    "category": "Anti-Assignment"
  },
  {
    "text": "Control (whether used as a noun or as a verb) or Controlled means, with respect to any Intellectual Property",
    "bbox": [
      303,
      397,
      1000,
      413
    ],
    "label": 18,
    "category": "Anti-Assignment"
  },
  {
    "text": "Right, Trademark or Know-How, the possession (whether by ownership or license, other than pursuant to this Agreement) by a Party",
    "bbox": [
      111,
      416,
      1000,
      431
    ],
    "label": 18,
    "category": "Anti-Assignment"
  },
  {
    "text": "of the ability to grant to the other Party access or a license as provided herein under such Intellectual Property Right, Trademark or",
    "bbox": [
      113,
      435,
      1000,
      448
    ],
    "label": 18,
    "category": "Anti-Assignment"
  },
  {
    "text": "Know-How without violating the terms of any agreement or other arrangements with any Third Party.",
    "bbox": [
      112,
      453,
      955,
      466
    ],
    "label": 18,
    "category": "Anti-Assignment"
  },
  {
    "text": "1.16",
    "bbox": [
      192,
      483,
      238,
      499
    ],
    "label": 18,
    "category": "Anti-Assignment"
  },
  {
    "text": "Damages shall have the meaning ascribed to it in Section 9.4.3..",
    "bbox": [
      302,
      484,
      830,
      499
    ],
    "label": 18,
    "category": "Anti-Assignment"
  },
  {
    "text": "1.17",
    "bbox": [
      192,
      518,
      238,
      533
    ],
    "label": 18,
    "category": "Anti-Assignment"
  },
  {
    "text": "Defend or Defense shall have the meaning ascribed to it in Section 9.4.2..",
    "bbox": [
      302,
      518,
      910,
      533
    ],
    "label": 18,
    "category": "Anti-Assignment"
  },
  {
    "text": "1.18",
    "bbox": [
      192,
      552,
      238,
      567
    ],
    "label": 18,
    "category": "Anti-Assignment"
  },
  {
    "text": "Development means all non-clinical and clinical research and drug development activities as well as.",
    "bbox": [
      304,
      554,
      1000,
      566
    ],
    "label": 18,
    "category": "Anti-Assignment"
  },
  {
    "text": "Manufacturing process development, upscaling of the Manufacturing process and chemistry, manufacturing and control development",
    "bbox": [
      112,
      571,
      1000,
      584
    ],
    "label": 18,
    "category": "Anti-Assignment"
  },
  {
    "text": "work conducted in respect of any pharmaceutical product, including those necessary to obtain Regulatory Approval for such",
    "bbox": [
      113,
      590,
      1000,
      603
    ],
    "label": 18,
    "category": "Anti-Assignment"
  },
  {
    "text": "pharmaceutical product. When used as a verb, Develop means to engage in Development.",
    "bbox": [
      112,
      608,
      866,
      622
    ],
    "label": 18,
    "category": "Anti-Assignment"
  },
  {
    "text": "1.19",
    "bbox": [
      192,
      640,
      237,
      655
    ],
    "label": 18,
    "category": "Anti-Assignment"
  },
  {
    "text": "Disclosing Party shall have the meaning ascribed to it in Section 11.1.",
    "bbox": [
      303,
      641,
      885,
      655
    ],
    "label": 18,
    "category": "Anti-Assignment"
  },
  {
    "text": "1.20",
    "bbox": [
      192,
      674,
      235,
      687
    ],
    "label": 18,
    "category": "Anti-Assignment"
  },
  {
    "text": "Effective Date shall have the meaning ascribed to it in the introductory paragraph above",
    "bbox": [
      303,
      674,
      1000,
      689
    ],
    "label": 18,
    "category": "Anti-Assignment"
  },
  {
    "text": "1.21",
    "bbox": [
      192,
      708,
      236,
      723
    ],
    "label": 18,
    "category": "Anti-Assignment"
  },
  {
    "text": "Existing Reference Product shall have the meaning ascribed to it in Section 1.61..",
    "bbox": [
      302,
      708,
      985,
      723
    ],
    "label": 18,
    "category": "Anti-Assignment"
  },
  {
    "text": "1.22",
    "bbox": [
      192,
      740,
      237,
      756
    ],
    "label": 18,
    "category": "Anti-Assignment"
  },
  {
    "text": "FDA means the United States Food and Drug Administration, and any successor agency thereto",
    "bbox": [
      302,
      741,
      1000,
      756
    ],
    "label": 18,
    "category": "Anti-Assignment"
  },
  {
    "text": "1.23",
    "bbox": [
      193,
      775,
      236,
      788
    ],
    "label": 18,
    "category": "Anti-Assignment"
  },
  {
    "text": "Field means any human use of the Licensed Product in the field of ophthalmology and for any other approved",
    "bbox": [
      302,
      774,
      1000,
      791
    ],
    "label": 18,
    "category": "Anti-Assignment"
  },
  {
    "text": "labelled indication of such Licensed Products..",
    "bbox": [
      113,
      794,
      487,
      806
    ],
    "label": 18,
    "category": "Anti-Assignment"
  },
  {
    "text": "1.24",
    "bbox": [
      192,
      826,
      237,
      842
    ],
    "label": 18,
    "category": "Anti-Assignment"
  },
  {
    "text": "First Commercial Sale means, with respect to any Licensed Product in the Territory, the first sale by",
    "bbox": [
      302,
      827,
      1000,
      842
    ],
    "label": 18,
    "category": "Anti-Assignment"
  },
  {
    "text": "Licensee or its Affiliates of such Licensed Product to a Third Party for use in the Field in the Territory, after such Licensed Product.",
    "bbox": [
      111,
      846,
      1000,
      859
    ],
    "label": 18,
    "category": "Anti-Assignment"
  },
  {
    "text": "has been granted Regulatory Approval for use in the Field in the Territory..",
    "bbox": [
      111,
      864,
      722,
      878
    ],
    "label": 18,
    "category": "Anti-Assignment"
  },
  {
    "text": "Source: COHERUS BIOSCIENCES, INC., 10-K, 2/27/2020",
    "bbox": [
      133,
      1000,
      580,
      1000
    ],
    "label": 18,
    "category": "Anti-Assignment"
  }
]